Key facts
- It has raised $948.1M; the latest was Later Stage VC ($550.0M) in Sep 2025.
- Notable investors include New Enterprise Associates, Redpoint Ventures, CapitalG, Oxeon Partners, CVS Health Ventures — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Strive Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Strive Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Strive Health
Developer of care delivery models designed to improve chronic kidney disease care. The company's models include leveraging comparative and predictive data and analytics to identify patients at risk and reinventing primary care to identify and treat kidney disease before the need for dialysis, enabling healthcare providers to cut inpatient utilization, increase the adoption of home dialysis and significantly improve patient outcomes and experience.
- Sector
- Healthcare
- HQ
- Denver, CO, United States
- Founded
- 2018
- Employees
- 540
- Website
- strivehealth.com/
- Ownership
- Privately Held (backing)
Strive Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Strive Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Strive Health in its N-PORT filings yet. We sweep new filings monthly.